Spark Therapeutics Stock
Your prediction
Pros and Cons of Spark Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Spark Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ironwood Pharmaceuticals | 1.740% | -9.794% | 14.379% | -20.455% | 31.579% | -66.072% | -63.351% |
| Novocure Ltd | -4.380% | 3.488% | 7.181% | -54.591% | 7.322% | -86.197% | -91.552% |
| Iovance Biotherapeutics Inc. | -2.020% | -1.534% | 9.357% | -67.049% | -13.427% | -64.125% | -94.958% |
News
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December
Prediction: Nvidia Stock Could Reach $360 Sooner Than You Think
Nvidia (NASDAQ: NVDA) is transforming from a graphics processing unit (GPU) champion to an artificial intelligence (AI) infrastructure cash engine. Learn about Blackwell, DGX Spark, and DGX Cloud
